Combination of Quercetin and 2-Methoxyestradiol enhances inhibition of human prostate cancer LNCaP and PC-3 cells xenograft tumor growth

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Yang, Feiya ^a   Song, Liming ^a   Wang, Huiping ^b   Wang, Jun ^c   Xu, Zhiqing ^d   Xing, Nianzeng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; BETA ACTIN; CASPASE 3; KI 67 ANTIGEN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; QUERCETIN; 2-METHOXYESTRADIOL; CHROMONE DERIVATIVE; ESTRADIOL; QUERCETAGETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CAPILLARY DENSITY; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROSTATE CANCER; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL TIME; TUMOR XENOGRAFT; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; DRUG SCREENING; METABOLISM; NUDE MOUSE; PATHOLOGY; PROSTATIC NEOPLASMS; TUMOR CELL LINE; XENOGRAFT;

MUS; MUS MUSCULUS;

ANIMALS; CELL LINE, TUMOR; CHROMONES; ESTRADIOL; HETEROGRAFTS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84930216510     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128277     Document Type: Article

References (49)

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64: 9-29. doi: 10. 3322/caac.21208 PMID: 24399786
2. Fleshner N (2005) Defining high-risk prostate cancer: current status. Can J Urol 12 Suppl 1: 14-17, 94-96. PMID: 15780159
3. Hotte SJ, Saad F (2010) Current management of castrate-resistant prostate cancer. Current Oncology 17: S72-S79. PMID: 20882137
4. Qu S, Wang K, Xue H, Wang Y, Wu R, Liu C, et al. (2014) Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft model. Molecular Oncology 8: 311-322. doi: 10.1016/j.molonc.2013.12.004 PMID: 24388358
5. Liu KC, Yen CY, Wu RS, Yang JS, Lu HF, Lu KW, et al. (2014) The roles of endoplasmic reticulum stress and mitochondrial apoptotic signaling pathway in quercetin-mediated cell death of human prostate cancer PC-3 cells. Environ Toxicol 29: 428-439. doi: 10.1002/tox.21769 PMID: 22431435
6. Wang P, Vadgama JV, Said JW, Magyar CE, Doan N, Heber D, et al. (2014) Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea. J Nutr Biochem 25: 73-80. doi: 10.1016/j.jnutbio.2013.09.005 PMID: 24314868
7. B?dziul D, Jakubowicz-Gil J, Paduch R, G?owniak K, Gawron A (2014) Combined treatment with quercetin and imperatorin as a potent strategy for killing HeLa and Hep-2 cells. Molecular and Cellular Biochemistry 392: 213-227. doi: 10.1007/s11010-014-2032-4 PMID: 24682729
8. Baran I, Ionescu D, Filippi A, Mocanu MM, Iftime A, Babes R, et al. (2014) Novel insights into the anti-proliferative effects and synergism of quercetin and menadione in human leukemia Jurkat T cells. Leukemia Research 38: 836-849. doi: 10.1016/j.leukres.2014.04.010 PMID: 24862793
9. Mueck AO, Seeger H (2010) 2-Methoxyestradiol-Biology and mechanism of action. Steroids 75: 625-631. doi: 10.1016/j.steroids.2010.02.016 PMID: 20214913
10. Ehteda A, Galettis P, Pillai K, Morris DL (2013) Combination of albendazole and 2-methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice. BMC Cancer 13: 86. doi: 10. 1186/1471-2407-13-86 PMID: 23432760
11. Van Veldhuizen PJ, Ray G, Banerjee S, Dhar G, Kambhampati S, Dhar A, et al. (2008) 2-Methoxyestradiol modulates β-catenin in prostate cancer cells: A possible mediator of 2-methoxyestradiol-induced inhibition of cell growth. International Journal of Cancer 122: 567-571.
12. Visagie M, Theron A, Mqoco T, Vieira W, Prudent R, Martinez A, et al. (2013) Sulphamoylated 2-Methoxyestradiol Analogues Induce Apoptosis in Adenocarcinoma Cell Lines. PLoS ONE 8: e71935. doi: 10.1371/journal.pone.0071935 PMID: 24039728
13. Reiner T, de Las PA, Gomez LA, Perez-Stable C (2009) Low dose combinations of 2-methoxyestradiol and docetaxel block prostate cancer cells in mitosis and increase apoptosis. Cancer Lett 276: 21-31. doi: 10.1016/j.canlet.2008.10.026 PMID: 19046802
14. Wang G, Song L, Wang H, Xing N (2013) Quercetin synergizes with 2-methoxyestradiol inhibiting cell growth and inducing apoptosis in human prostate cancer cells. Oncol Rep 30: 357-363. doi: 10.3892/or.2013.2469 PMID: 23673431
15. Ferruelo A, Romero I, Cabrera PM, Arance I, Andres G, Angulo JC. (2014) Effects of resveratrol and other wine polyphenols on the proliferation, apoptosis and androgen receptor expression in LNCaP cells. Actas Urol Esp 38: 397-404. doi: 10.1016/j.acuro.2014.02.012 PMID: 24726691
16. Song J, Song Y, Guo W, Jia J, Jin Y, Bai A. (2014) Regulatory roles of KDR antisense oligonucleotide on the proliferation of human prostate cancer cell line PC-3. J BUON 19: 770-774. PMID: 25261665
17. Xu H, Yu X, Qu S, Sui D (2013) Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells. Bioorg Med Chem Lett 23: 3631-3634. doi: 10.1016/j.bmcl.2013.04.007 PMID: 23643730
18. Borghetti GS, Lula IS, Sinisterra RD, Bassani VL (2009) Quercetin/beta-cyclodextrin solid complexes prepared in aqueous solution followed by spray-drying or by physical mixture. AAPS PharmSciTech 10: 235-242. doi: 10.1208/s12249-009-9196-3 PMID: 19280349
19. Sharmila G, Bhat FA, Arunkumar R, Elumalai P, Raja SP, Senthilkumar K, et al. (2014) Chemopreventive effect of quercetin, a natural dietary flavonoid on prostate cancer in in vivo model. Clin Nutr 33: 718-726. doi: 10.1016/j.clnu.2013.08.011 PMID: 24080313
20. Ma ZS, Huynh TH, Ng CP, Do PT, Nguyen TH, Huynh H. (2004) Reduction of CWR22 prostate tumor xenograft growth by combined tamoxifen-quercetin treatment is associated with inhibition of angiogenesis and cellular proliferation. Int J Oncol 24: 1297-1304. PMID: 15067354
21. Ma Z, Hung NT, Hoa HT, Tien DP, Huynh H (2004) Reduction of rat prostate weight by combined quercetin-finasteride treatment is associated with cell cycle deregulation. J Endocrinol 181: 493-507. PMID: 15171697
22. Casarez EV, Dunlap-Brown ME, Conaway MR, Amorino GP (2007) Radiosensitization and modulation of p44/42 mitogen-activated protein kinase by 2-Methoxyestradiol in prostate cancer models. Cancer Res 67: 8316-8324. PMID: 17804747
23. Qadan LR, Perez-Stable CM, Anderson C, D'Ippolito G, Herron A, Howard GA, et al. (2001) 2-Methoxyestradiol Induces G2/M Arrest and Apoptosis in Prostate Cancer. Biochemical and Biophysical Research Communications 285: 1259-1266. PMID: 11478793
24. Xing N, Chen Y, Mitchell SH, Young CY (2001) Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Carcinogenesis 22: 409-414. PMID: 11238180
25. Cialdella-Kam L, Nieman DC, Sha W, Meaney MP, Knab AM, Shanely RA. (2013) Dose-response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults. British Journal of Nutrition 109: 1923-1933. doi: 10.1017/S0007114512003972 PMID: 23151341
26. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J (1999) Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 54: 960-963. PMID: 10604689
27. Harrison MR, Hahn NM, Pili R, Oh WK, Hammers H, Sweeney C, et al. (2011) A phase II study of 2- methoxyestradiol (2ME2) NanoCrystal1 dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC). Investigational New Drugs 29: 1465-1474. doi: 10.1007/s10637-010-9455-x PMID: 20499131
28. Tevaarwerk AJ, Holen KD, Alberti DB, Sidor C, Arnott J, Quon C, et al. (2009) Phase I Trial of 2-Methoxyestradiol NanoCrystal Dispersion in Advanced Solid Malignancies. Clinical Cancer Research 15: 1460-1465. doi: 10.1158/1078-0432.CCR-08-1599 PMID: 19228747
29. Wang P, Heber D, Henning SM (2012) Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells. Nutr Cancer 64: 580-587. doi: 10. 1080/01635581.2012.661514 PMID: 22452782
30. Kumar R, Verma V, Jain A, Jain RK, Maikhuri JP, Gupta G, et al. (2011) Synergistic chemoprotective mechanisms of dietary phytoestrogens in a select combination against prostate cancer. The Journal of Nutritional Biochemistry 22: 723-731. doi: 10.1016/j.jnutbio.2010.06.003 PMID: 21062672
31. Ghosh R, Ganapathy M, Alworth WL, Chan DC, Kumar AP (2009) Combination of 2-methoxyestradiol (2-ME2) and eugenol for apoptosis induction synergistically in androgen independent prostate cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 113: 25-35. doi: 10.1016/j.jsbmb.2008.11.002 PMID: 19084597
32. Chang YF, Hsu YC, Hung HF, Lee HJ, Lui WY, Chi CW, et al. (2009) Quercetin induces oxidative stress and potentiates the apoptotic action of 2-methoxyestradiol in human hepatoma cells. Nutr Cancer 61:735-745. doi: 10.1080/01635580902825571 PMID: 19838948
33. Mehta RG, Murillo G, Naithani R, Peng X (2010) Cancer chemoprevention by natural products: how far have we come? Pharm Res 27: 950-961. doi: 10.1007/s11095-010-0085-y PMID: 20238150
34. Brunelle JK, Letai A (2009) Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci 122: 437-441. doi: 10.1242/jcs.031682 PMID: 19193868
35. Basu A, Haldar S (2003) Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis. FEBS Letters 538: 41-47. PMID: 12633850
36. Bu S, Blaukat A, Fu X, Heldin NE, Landstr M M (2002) Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells. FEBS letters 531: 141-151. PMID: 12417302
37. Senthilkumar K, Elumalai P, Arunkumar R, Banudevi S, Gunadharini ND, Sharmila G, et al. (2010) Quercetin regulates insulin like growth factor signaling and induces intrinsic and extrinsic pathway mediated apoptosis in androgen independent prostate cancer cells (PC-3). Mol Cell Biochem 344: 173-184. doi: 10.1007/s11010-010-0540-4 PMID: 20658310
38. Morgan TM, Koreckij TD, Corey E (2009) Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway. Curr Cancer Drug Targets 9: 237-249. PMID: 19275762
39. Kim Y, Lee YJ (2007) TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation. Journal of Cellular Biochemistry 100: 998-1009. PMID: 17031854
40. Lee DH, Szczepanski M, Lee YJ (2008) Role of Bax in quercetin-induced apoptosis in human prostate cancer cells. Biochem Pharmacol 75: 2345-2355. doi: 10.1016/j.bcp.2008.03.013 PMID: 18455702
41. Shimada K, Nakamura M, Ishida E, Kishi M, Matsuyoshi S, Konishi N. (2004) The molecular mechanism of sensitization to Fas-mediated apoptosis by 2-methoxyestradiol in PC3 prostate cancer cells. Molecular Carcinogenesis 39: 1-9. PMID: 14694442
42. Yu PC, Gu SY, Bu JW, Du JL (2010) TRPC1 is essential for in vivo angiogenesis in zebrafish. Circ Res 106: 1221-1232. doi: 10.1161/CIRCRESAHA.109.207670 PMID: 20185799
43. Pratheeshkumar P, Budhraja A, Son YO, Wang X, Zhang Z, Ding S, et al. (2012) Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways. PLoS One 7: e47516. doi: 10.1371/journal.pone.0047516 PMID: 23094058
44. Lee DH, Lee YJ (2008) Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis. J Cell Biochem 105: 546-553. doi: 10.1002/jcb.21851 PMID: 18655183
45. Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, et al. (2003) 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3:363-375. PMID: 12726862
46. Miyata Y, Mitsunari K, Asai A, Takehara K, Mochizuki Y, Sakai H. (2015) Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy. Prostate 75: 84-91. doi: 10.1002/pros.22894 PMID: 25307287
47. Miyata Y, Ohba K, Matsuo T, Watanabe S, Hayashi T, Sakai H, et al. (2013) Tumor-associated stromal cells expressing E-prostanoid 2 or 3 receptors in prostate cancer: correlation with tumor aggressiveness and outcome by angiogenesis and lymphangiogenesis. Urology 81: 136-142. doi: 10.1016/j.urology.2012.08.014 PMID: 23149328
48. Erbersdobler A, Isbarn H, Dix K, Steiner I, Schlomm T, Mirlacher M, et al. (2010) Prognostic value of microvessel density in prostate cancer: a tissue microarray study. World J Urol 28: 687-692. doi: 10.1007/s00345-009-0471-4 PMID: 19714336
49. Bettencourt MC, Bauer JJ, Sesterhenn IA, Connelly RR, Moul JW (1998) CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy. J Urol 160: 459-465. PMID: 9679898